A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older Adults
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07885956. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF A SECOND DOSE OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE GIVEN 5 YEARS AFTER THE INITIAL DOSE IN OLDER ADULTS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is testing the safety and tolerability of a second dose of Respiratory Syncytial Virus Vaccine (RSVpreF) given approximately 5 years after the initial dose.
Study identification
- NCT ID
- NCT07885956
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 750 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2026 (Estimated)
- Primary completion
- Feb 7, 2029 (Estimated)
- Completion
- Feb 7, 2029 (Estimated)
- Last update posted
- Nov 20, 2026
2026 – 2029
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fiel Family and Sports Medicine/Avacare Clinical Research Network | Tempe | Arizona | 85283 | — |
| West Coast Research | Dublin | California | 94568 | — |
| Universal Axon Clinical Research | Doral | Florida | 33166 | — |
| Rovia - Palmetto Bay | Miami | Florida | 33176 | — |
| DBC Research USA | Pembroke Pines | Florida | 33029 | — |
| Javara Inc | Albany | Georgia | 31707 | — |
| Solaris Clinical Research | Meridian | Idaho | 83646 | — |
| Summit Headlands LLC | Portland | Oregon | 97210 | — |
| Accellacare US Inc., d/b/a Accellacare of Knoxville | Knoxville | Tennessee | 37912 | — |
| DM Clinical Research-Tomball | Tomball | Texas | 77375 | — |
| J. Lewis Research Inc. / Foothill Family Clinic Draper | Draper | Utah | 84020 | — |
| J. Lewis Research, Inc/Jordan River Family Medicine | South Jordan | Utah | 84095 | — |
| Sound Health Care Center | Port Orchard | Washington | 98366 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07885956, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2026 · Synced Nov 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.